{"disease":{"id":"focal-cortical-dysplasia","name":"focal cortical dysplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03321240","title":"Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06053671","title":"Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT06965881","title":"Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"GRIN Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03198949","title":"A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06975605","title":"Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"GRIN Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06116279","title":"First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":6,"lead_sponsor_name":"Great Ormond Street Hospital for Children NHS Foundation Trust","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}